For This Week in Cardiology September 4, 2015, Dr John Mandrola comments on the following cardiology news and features stories:
PLATFORM: CT-Derived FFR Reduces Unnecessary Caths in Stable CAD
MATRIX: Is There A Benefit From Longer Bivalirudin Infusion?
IMPROVE-IT: Diabetics Benefit With Ezetimibe, but Is It Enough?
BACC: High-Sensitivity Troponin I Test Accelerates MI Triage
PATHWAY2: Spironolactone Effective in Lowering Blood Pressure in Resistant Hypertension
St Jude Leadless Pacemaker Shows Potential in US Premarket Study
Siesta Therapy: Midday Napping Could Help Lower BP in Patients Treated for Hypertension
Chief Cardiology Correspondent
John M Mandrola, MD, Clinical Electrophysiologist, Baptist Medical Associates, Louisville, Kentucky
Disclosure: John M. Mandrola, MD, has disclosed the following relevant financial relationships:
Served as a speaker or member of a speakers bureau for: Biosense/Webster
© 2015 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Sep 4 Cardiology News Podcast - Medscape - Sep 04, 2015.
Comments